Durable complete response is achieved by balloon‐occluded transcatheter arterial chemoembolization for hepatocellular carcinoma

Durable complete response is achieved by balloon‐occluded transcatheter arterial chemoembolization for hepatocellular carcinoma

Abstract In 2013 and 2014, the development of microcatheters with balloons for the 4‐Fr system and new embolization materials provided various options for transarterial chemoembolization (TACE), expanding the range of treatment strategies. At our hospital, balloon‐occluded TACE (B‐TACE), conventiona...

Full description

Bibliographic Details
Main Authors:	Tomotake Shirono, Hideki Iwamoto, Takashi Niizeki, Shigeo Shimose, Akira Kajiwara, Hiroyuki Suzuki, Naoki Kamachi, Yu Noda, Shusuke Okamura, Masahito Nakano, Ryoko Kuromatsu, Kenta Murotani, Hironori Koga, Takuji Torimura
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2022-09-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.2016

Similar Items

Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast‐enhanced ultrasound
by: Naoki Kamachi, et al.
Published: (2022-02-01)

Usefulness of a novel transarterial chemoinfusion plus external‐beam radiation therapy for advanced hepatocellular carcinoma with tumor thrombi in the inferior vena cava and right atrium: Case study
by: Tomotake Shirono, et al.
Published: (2022-08-01)

Efficacy of Atezolizumab Plus Bevacizumab–Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
by: Etsuko Moriyama, et al.
Published: (2024-09-01)

Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis
by: Masahito Nakano, et al.
Published: (2020-08-01)

Case Report: Exacerbation of varices following atezolizumab plus bevacizumab treatment of hepatocellular carcinoma: A case series and literature review
by: Hiroyuki Suzuki, et al.
Published: (2022-07-01)

DNA Methylation in Noncancerous Liver Tissues as Biomarker for Multicentric Occurrence of Hepatitis C Virus–Related Hepatocellular Carcinoma
by: Hiroyuki Suzuki, et al.
Published: (2022-01-01)

The Immune Inductive Role of Hepatic Arterial Infusion Chemotherapy Prior to Atezolizumab Plus Bevacizumab Combination Therapy in Hepatocellular Carcinoma
by: Hiroyuki Suzuki, et al.
Published: (2024-01-01)

Deterioration of liver function and aging disturb sequential systemic therapy for unresectable hepatocellular carcinoma
by: Shigeo Shimose, et al.
Published: (2022-10-01)

Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
by: Hideki Iwamoto, et al.
Published: (2022-07-01)

The impact of curative conversion therapy aimed at a cancer‐free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
by: Shigeo Shimose, et al.
Published: (2023-06-01)

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
by: Hideki Iwamoto, et al.
Published: (2023-07-01)

Tumor‐derived insulin‐like growth factor‐binding protein‐1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors
by: Hiroyuki Suzuki, et al.
Published: (2023-04-01)

First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study
by: Shigeo Shimose, et al.
Published: (2021-12-01)

Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection.
by: Shuji Sumie, et al.
Published: (2011-01-01)

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
by: Hironori Koga, et al.
Published: (2023-04-01)

Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma
by: Shigeo Shimose, et al.
Published: (2021-10-01)

Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
by: Hiroyuki Suzuki, et al.
Published: (2024-04-01)

Preoperative Balloon-Occluded Transcatheter Arterial Chemoembolization Followed by Surgical Resection: Pathological Evaluation of Necrosis
by: Jihoon Kim, et al.
Published: (2023-10-01)

In Vitro Model for Simulating Drug Delivery during Balloon-Occluded Transarterial Chemoembolization
by: Jorge Aramburu, et al.
Published: (2021-12-01)

Balloon-occluded chemoembolization for hepatocellular carcinoma: a prospective study of safety, feasibility and outcomes
by: Ana-Maria Bucalau, et al.
Published: (2021-03-01)

Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching
by: Rita Golfieri, et al.
Published: (2021-07-01)

New Method of Parent Catheter Advancement in the Balloon Anchor Technique during Balloon-Occluded Transarterial Chemoembolization for Hepatic Tumors
by: Kei Shibuya, et al.
Published: (2016-01-01)

Recent technical advances in conventional transarterial chemoembolization for hepatocellular carcinoma in Japan
by: Hiroki Higashihara, et al.
Published: (2021-10-01)

Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells
by: Dan Nakano, et al.
Published: (2022-04-01)

Transcatheter arterial chemoembolization plus Sorafenib versus transcatheter arterial chemoembolization plus Lenvatinib for intermediate hepatocellular carcinoma
by: Moxuan Wang, et al.
Published: (2024-10-01)

Transcatheter arterial infusion chemotherapy with cisplatin in combination with transcatheter arterial chemoembolization decreases intrahepatic distant recurrence of unresectable hepatocellular carcinoma
by: Naoto Kawabe, et al.
Published: (2021-06-01)

Occluded or Not?
by: Anne-Flore Plane, MD, et al.
Published: (2019-12-01)

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
by: Hideki Iwamoto, et al.
Published: (2011-03-01)

Cure of Hepatoblastoma Through Transcatheter Arterial Chemoembolization
by: Tianyou Yang, et al.
Published: (2017-11-01)

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
by: Kobayashi S, et al.
Published: (2020-10-01)

Successful treatment of a patient with chyluria due to lymphangioleiomyomatosis using sirolimus
by: Takahiko Sakaue, et al.
Published: (2018-01-01)

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
by: Rong Cai, et al.
Published: (2017-11-01)

Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis
by: Xin Liu, et al.
Published: (2023-09-01)

Occluded algorithms
by: Adam Burke
Published: (2019-07-01)

Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
by: Takumi Kawaguchi, et al.
Published: (2022-04-01)

Pulmonary lipiodol embolism following transcatheter arterial chemoembolization
by: Tomohiro Moriya, et al.
Published: (2020-12-01)

Transcatheter closure of the aortopulmonary window with a multifunctional occluder device
by: Amit Mandal
Published: (2023-01-01)

Transcatheter closure of aortopulmonary window with Amplatzer duct occluder II
by: Hemant Kumar Nayak, et al.
Published: (2017-01-01)

Cell cycle regulation by the Wee1 Inhibitor PD0166285, Pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line
by: Sakamoto Masaharu, et al.
Published: (2006-12-01)

Transcatheter closure of hypertensive ductus with amplatzer post infarction muscular VSD occluder after percutaneous retrieval of embolized amplatzer duct occluder
by: Milind S Phadke, et al.
Published: (2014-01-01)